Adult Inpatient Antibiogram. Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates. January to December 2016

Size: px
Start display at page:

Download "Adult Inpatient Antibiogram. Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates. January to December 2016"

Transcription

1 Adult Inpatient Antibiogram Antimicrobial Susceptibilities of Frequently Recovered Clinical Isolates January to December 2016 Department of Pathology Camille Hamula, PhD Director, Clinical Microbiology Laboratory Department of Medicine, Division of Infectious Diseases Judith Aberg, MD Chief, Infectious Diseases Gopi Patel, MD MS Director, Antimicrobial Stewardship Program Hospital Epidemiologist Meena Rana, MD Associate Director, Antimicrobial Stewardship Program Department of Pharmacy Joanne Meyer, MS PharmD Chief Pharmacy Officer, Mount Sinai Health System Patricia L. Saunders-Hao, PharmD Gargi Patel, PharmD Polina Lerner, PharmD ID Clinical Pharmacists, Antibiotic Stewardship Program Contact Information: Microbiology Ext Infection Prevention Ext Antibiotic Approval Pager 9407

2 Agent (avg. cost/day) Dosing Recommendations Based on Renal Function Estimated CrCl (ml/min) > <10 Supplement for HD/CAPD/CVVH/CAVH Ampicillin/ sulbactam ($14) Aztreonam ($198) Cefazolin ($9) Cefepime ($21) Colistin 2 ($18) Daptomycin 3 ($260) Ertapenem ($90) Fluconazole 4 ($3 IV/ $ 3 PO) Imipenem/ cilastatin ($40) Levofloxacin ($3 IV/ $0.37 PO) Meropenem ($30) Piperacillin/ tazobactam ($40) q8-12h 5 in 2-3 1g IV mg mg 1-2g IV g IV in 2 mg/kg IV 1 g IV mg 1-2g IV 1-2g IV 1.5 in 2 0.5g IV 750 mg x1, then 500 mg (CrCl < 20) 0.5 1g IV 1-2g IV 1g IV or 2g IV 0.5g - 1g IV 1.5 mg/kg IV q36h 2 0.5g IV 250 mg IV 750 mg x1, then mg 0.5-1g IV CAPD: 3g IV CVVH/CAVH: 3g IV q8-12h, Extra 0.5g AD 1 CVVH/CAVH: CAPD: 500mg IV CVVH/CAVH: 1-2g IV CAPD: 1-2 g IV CVVH/CAVH: 1-2g 1 HEMO: 2.5 mg/kg AD CVVH: 2.5 divided in 2 doses HEMO (MWF or TThSa): 6 mg/kg post HD for 2 sessions; 9mg/kg post HD for 3 rd session HEMO (PRN): 6mg/kg post HD CAPD: mg/kg CVVH: mg/kg ; if dosed <6 hrs prior to HD, give 150 mg supplement AD* HEMO: 100% of dose AD 1 CAPD: mg CVVH: mg HEMO: CAPD: 250 mg IV CVVH/CAVH: 500mg IV CVVH/CAVH: mg CVVH/CAVH: 1g CVVH/CAVH: g IV 1 AD= after dialysis; Antibiotics should be dosed after dialysis on HD days. If dose is given right before HD, then a supplemental dose may be required. 2 Always consider using loading dose on day one: 5 x IBW (max of 300mg); wait 24hrs before giving next dose 3 Dosing (6-12mg/kg) depends on severity and pathogen consult ID 4 Consider loading dose (12mg/kg max) for treatment of invasive candidiasis infections FORMULARY ANTIMICROBIAL AGENTS REQUIRING APPROVAL AT ALL TIMES (24/7) Acyclovir IV (pediatrics only) Foscarnet Voriconazole Amphotericin B Isavuconazole Caspofungin Linezolid Antimalaria medications: Ceftaroline Pentamidine inhaled - Atovaquone/proguanil Cidofovir Polymyxin B - Primaquine Colistin Posaconazole - Quinidine IV (if for malaria) Cytomegalovirus IVIG Tigecycline - Quinine Daptomycin Varicella Zoster IVIG

3 VANCOMYCIN DOSING CrCl (ml/min) Vancomycin Dosing > 70 ml/min 15 mg/kg every ml/min 15 mg/kg every ml/min 15 mg/kg every <20 ml/min 15 mg/kg x 1, then re-dose by level HD/CAPD CVVH 15 mg/kg x 1, then re-dose by level 1 g IV every 24 Doses are based on actual body weight Doses should be rounded to the nearest 250 mg (maximum 2 g per dose) Consultation with an Infectious Disease specialist is strongly recommended for Staphylococcus aureus bacteremia (irrespective of source and susceptibilities) Am J Health-Syst Pharm. 2009; 66:82-98 VANCOMYCIN MONITORING Trough serum concentrations are the most accurate and practical method for monitoring efficacy and avoiding adverse effects Troughs should be obtained just prior to the next dose when patient at steady-state (usually before 4 th or 5 th dose) o Minimum serum trough levels should always be maintained > 10 mg/l o Minimum serum trough levels of mg/l are recommended for complicated infections (endocarditis, osteomyelitis, meningitis, and staphylococcal pneumonia)

4 ADULT AMINOGLYCOSIDE DOSING Once daily dosing of aminoglycosides is recommended for the treatment of Gram-negative infections. An Infectious Diseases (ID) or ID Pharmacist consultation is recommended. Exclusions to Once Daily Dosing Avoid aminoglycosides in neuromuscular disease Traditional dosing is preferred for: o CrCl < 20ml/min or HD o Burns (involving >20% BSA) o Pregnancy o Significant ascites or patients with significant third spacing Calculating Dose Dosing is based on Ideal Body Weight (IBW) In obese patients (>120% IBW) use Adjusted Body Weight (ABW) o ABW= IBW + 0.4(actual body weight IBW) If actual body weight is under IBW, use actual body weight CrCl (ml/min) Aminoglycoside Once Daily Initial Dose Gentamicin OR > 60 7 mg/kg every mg/kg every to 59 7 mg/kg every mg/kg every mg/kg every mg/kg every 48 <20 or HD Use traditional AG dosing protocol

5 ONCE DAILY AMINOGLYCOSIDE MONITORING Order a random level 8-10 after the beginning of the infusion. Please communicate with the nursing staff. Plot the level on the nomogram below based on when it was drawn. Nomogram for Gentamicin & at 7mg/kg**: If the point is near the line, the longer interval is chosen to avoid drug accumulation and provide sufficient drug-free period. If the random level is off (i.e., above) the nomogram between the 6- and 14- hr time points, the scheduled therapy is discontinued and the drug concentration is monitored to determine appropriate time of the next dose (i.e,concentration of <1 µg/ml) If level falls in area designated, the dosing interval is (the same applies for the areas q36h and ) Adopted from Hartford Hospital **: Divide amikacin level by 2 and plot above TIPS ON EVALUATING LEVELS AND REPEAT MONITORING: If the level falls on a line, the longer dosage interval should be selected. If the level falls above the Q 48H line: The drug should be held. o Serial random levels should be followed until <1mcg/mL If initial level falls below the nomogram, consider going to traditional dosing Repeat serum AG levels as necessary, with significant changes in CrCl or when therapy continues beyond 96 after previous level and every 96 to minimize toxicity. Patients on concurrent nephrotoxic agents (diuretics, vancomycin, contrast, etc) o Recommend monitor level twice a week and monitor BUN and Cr daily CrCl (ml/min) Traditional Aminoglycoside Dosing Gentamicin**/ **For Gram-positive endocarditis, use 1mg/kg Monitoring Traditional Dosing Gentamicin/ > mg/kg every 8 5mg/kg every 8 Target Peaks/Troughs: <20 1-2mg/kg every mg/kg every mg/kg every 48 5mg/kg every 12 5mg/kg every 24 5mg/kg loading dose, then monitor levels <10 1-2mg/kg after HD 5mg/kg after HD Sepsis/Pneumonia: 7-10/ <2 OB-GYN: 5-7/ <2 **Synergy for Enterococcal or Streptococcal Endocarditis (Gent 1mg/kg): 2-4/ <1 Target Peaks/Troughs: Sepsis/Pneumonia: 20-30/ <10 UTI/Cystitis: 10-15/ <7 5/ <7

MONTEFIORE MEDICAL CENTER

MONTEFIORE MEDICAL CENTER DEPARTMENT OF PHARMACY MONTEFIORE MEDICAL CENTER SUBJECT: MANUAL CODE: Restricted Drugs Policy, Antibiotic Restriction PH-R-5 DATE ISSUED: August, 1976 DATE REVISED: September 2000, October 2003, September

More information

Adult Institutional Pharmacokinetics Protocol

Adult Institutional Pharmacokinetics Protocol Adult Institutional Pharmacokinetics Protocol Policy Title: Clinical Pharmacokinetics (PK) Service Policy Policy Statement: It is the policy of UMHC that PK consult orders (for vancomycin or aminoglycosides)

More information

SBUH Aminoglycoside Dosing Protocol

SBUH Aminoglycoside Dosing Protocol Adult Aminoglycoside Dosing for Gram negative infections prior to available serum levels (Excludes patients with cystic fibrosis, OB GYN patients and surgical prophylaxis) Cr Cl 40 ml/min 5 7 mg/kg INT

More information

VANCOMYCIN DOSING AND MONITORING GUIDELINES

VANCOMYCIN DOSING AND MONITORING GUIDELINES VANCOMYCIN DOSING AND MONITORING GUIDELINES NB Provincial Health Authorities Anti-Infective Stewardship Committee Approved: May 2017 GENERAL COMMENTS Vancomycin is a glycopeptide antibiotic with bactericidal

More information

(Max 2 g) = to nearest 250 mg

(Max 2 g) = to nearest 250 mg Appendix 1 (part 1 of 8): Rubric for competency assessment of pharmacists prescribing and managing vancomycin Empiric Dosing Phase Pts Yes No Data Error OP Did the pharmacist document the indication 2

More information

IMPROVING VANCOMYCIN DOSING AND MONITORING IN THE ABSENCE OF A FORMAL PHARMACOKINETIC SERVICE:

IMPROVING VANCOMYCIN DOSING AND MONITORING IN THE ABSENCE OF A FORMAL PHARMACOKINETIC SERVICE: IMPROVING VANCOMYCIN DOSING AND MONITORING IN THE ABSENCE OF A FORMAL PHARMACOKINETIC SERVICE: IMPACT OF A PHARMACY DEPARTMENT-WIDE APPROACH IN A COMMUNITY HOSPITAL SETTING November 2014 Monica Dorobisz,

More information

Policy: Created: 2/11/2015; Approved: Adult Pharmacokinetic Dosing and Monitoring- Vancomycin Dosing

Policy: Created: 2/11/2015; Approved: Adult Pharmacokinetic Dosing and Monitoring- Vancomycin Dosing ProMedica Health System Clinical Interdepartmental Policy and Procedure: Section: Policy: Date: Subject: Pharmacy Created: 2/11/2015; Approved: Adult Pharmacokinetic Dosing and Monitoring- Vancomycin Dosing

More information

Use ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW:

Use ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW: Amikacin is a partially restricted (amber) antibiotic for the treatment of infections due to gentamicin resistant Gram negative bacilli or as advised by microbiology. As with other aminoglycosides, therapeutic

More information

TDM of Aminoglycoside Antibiotics

TDM of Aminoglycoside Antibiotics TDM Lecture 3 5 th Stage TDM of Aminoglycoside Antibiotics The aminoglycoside antibiotics are widely used for the treatment of gram-negative infections, often in combination with a β-lactam antibiotic

More information

BSWH Pharmacist Continuing Education PART 5: Pharmacotherapy and Pharmacokinetics in Adults: Aminoglycosides and Vancomycin

BSWH Pharmacist Continuing Education PART 5: Pharmacotherapy and Pharmacokinetics in Adults: Aminoglycosides and Vancomycin BSWH Pharmacist Continuing Education 2015 PART 5: Pharmacotherapy and Pharmacokinetics in Adults: Aminoglycosides and Vancomycin Objectives Define basic pharmacodynamic and pharmacokinetic principles Describe

More information

Adult Dose. Adults Day 1: 1mg/kg daily Day 2: 2mg/kg daily Day 3 onwards: 3mg/kg daily. Where appropriate consider rounding dose to nearest 50mg.

Adult Dose. Adults Day 1: 1mg/kg daily Day 2: 2mg/kg daily Day 3 onwards: 3mg/kg daily. Where appropriate consider rounding dose to nearest 50mg. AMIKACIN All ages>1month: 30mg/kg daily 1.5g once daily IV infusion over 30-60 Monitor renal function before treatment and weekly. Caution if used with other nephrotoxic drugs. Levels required. Trough

More information

Drug Typical Dose CrCl (ml/min) Dose adjustment for renal insufficiency Acyclovir PO (HSV) 400 mg TID >10 <10 or HD PD

Drug Typical Dose CrCl (ml/min) Dose adjustment for renal insufficiency Acyclovir PO (HSV) 400 mg TID >10 <10 or HD PD Antimicrobial Dosing in Renal Insufficiency (Adults) ASP Handbook * In patients on hemodialysis (), give antimicrobial immediately after dialysis on dialysis days. = Intermittent hemodialysis = Peritoneal

More information

Antimicrobial Reference Laboratory

Antimicrobial Reference Laboratory Antimicrobial Reference Laboratory GUIDELINE RANGES FOR TDM 2016-17 Andrew Lovering Antimicrobial Reference Laboratory North Bristol NHS Trust Southmead Hospital Bristol, BS10 5NB UK Aminoglycosides Gentamicin

More information

Approved by: SMG Origination Date: 06/14 Expiration Date: 06/17 Review Date: Revision Date: POLICY and PROCEDURE Archived Date: Page 1 of 14

Approved by: SMG Origination Date: 06/14 Expiration Date: 06/17 Review Date: Revision Date: POLICY and PROCEDURE Archived Date: Page 1 of 14 POLICY and PROCEDURE Archived Date: Page 1 of 14 PURPOSE In order to provide consistent and optimal vancomycin and aminoglycoside dosing and monitoring, a pharmacokinetic (PK) service will be provided

More information

Full title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control

Full title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control Full title of guideline Author: Contact Name and Job Title Division and specialty Scope Explicit definition of patient group to which it applies (e.g. inclusion and exclusion criteria, diagnosis) Changes

More information

Antimicrobial Reference Laboratory

Antimicrobial Reference Laboratory Antimicrobial Reference Laboratory GUIDELINE RANGES FOR TDM 2018 Andrew Lovering Antimicrobial Reference Laboratory North Bristol NHS Trust Southmead Hospital Bristol, BS10 5NB Guideline Ranges 2018 Aminoglycosides

More information

D DAVID PUBLISHING. 1. Introduction. Kathryn Koliha 1, Julie Falk 1, Rachana Patel 1 and Karen Kier 2

D DAVID PUBLISHING. 1. Introduction. Kathryn Koliha 1, Julie Falk 1, Rachana Patel 1 and Karen Kier 2 Journal of Pharmacy and Pharmacology 5 (2017) 607-615 doi: 10.17265/2328-2150/2017.09.001 D DAVID PUBLISHING Comparative Evaluation of Pharmacist-Managed Vancomycin Dosing in a Community Hospital Following

More information

AMINOGLYCOSIDES DOSING AND MONITORING GUIDELINES

AMINOGLYCOSIDES DOSING AND MONITORING GUIDELINES Approved: September 2017 AMINOGLYCOSIDES DOSING AND MONITORING GUIDELINES NB Provincial Health Authorities Anti-Infective Stewardship Committee GENERAL COMMENTS Aminoglycosides (AG) include gentamicin,

More information

Both adult and pediatric* 24 (46% of 52 members) Region: New England 51 (48% of 107 members) 45 (52% of 87 members) 29 (47% of 62 members)

Both adult and pediatric* 24 (46% of 52 members) Region: New England 51 (48% of 107 members) 45 (52% of 87 members) 29 (47% of 62 members) Infectious Diseases Society of America Emerging Infections Network Report for Query: Antimicrobial Drug Shortages 2016 Overall response rate: 701/1,597 (44%) physicians responded from 3/22/16 to 4/13/16.

More information

Initiating Aminoglycosides Safely. Last updated: July 2016, Version 5 Questions/Comments?

Initiating Aminoglycosides Safely. Last updated: July 2016, Version 5 Questions/Comments? Initiating Aminoglycosides Safely Last updated: July 2016, Version 5 Questions/Comments? Email Mark.McIntyre@uhn.ca Click orange buttons to navigate protocol. Index: Aminoglycoside Dosing Algorithms Objective

More information

Clinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult)

Clinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult) VANCOMYCIN (Adult) Please always prescribe VANCOMYCIN in the Variable Dose Antibiotic section of the EPMA SUPPLEMENTARY drug chart (and add a placeholder on the electronic drug chart). 1 Background Vancomycin

More information

Antimicrobial Stewardship: A System- Wide Approach at Carolinas HealthCare System

Antimicrobial Stewardship: A System- Wide Approach at Carolinas HealthCare System Antimicrobial Stewardship: A System- Wide Approach at Carolinas HealthCare System Kelly Goodson, PharmD; Erin Roach, Pharmd; Susan Bear, PharmD; Lisa Davidson, MD Carolinas HealthCare System is one of

More information

IV 5 mg/kg q12h 5 mg/kg q24h 2.5 mg/kg q24h mg/kg q24h (post HD) 50% standard dose q24h 5 mg/kg q24h. IV 5-10 mg/kg q12h

IV 5 mg/kg q12h 5 mg/kg q24h 2.5 mg/kg q24h mg/kg q24h (post HD) 50% standard dose q24h 5 mg/kg q24h. IV 5-10 mg/kg q12h Page 1 of 18 male: = (140-Age) IBW Drug Name Usual Dose (Normal Renal Function) CrCl (ml/min) Dose Adjustment (In renal insufficiency) Acyclovir (Zovirax) *Use IBW Mucosal & cutaneous IV: 5 mg/kg q8h PO:

More information

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS

INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Title of guideline (must include the word Guideline (not protocol, policy, procedure etc) INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Author: Contact Name and Job Title

More information

ADULT ANTIMICROBIAL DOSING TOOL (NB Provincial Health Authorities Anti-Infective Stewardship Committee, September 2017)

ADULT ANTIMICROBIAL DOSING TOOL (NB Provincial Health Authorities Anti-Infective Stewardship Committee, September 2017) (NB Provincial Health Authorities Anti-Infective Stewardship Committee, September 2017) Introduction The dosing recommendations presented here are for adults with moderate-to-severe infections and are

More information

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults

Trust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults A clinical guideline recommended for use: In: By: For: Division responsible for document: Key words: Names of document authors: Job titles of document authors: Name of document author s Line Manager: Job

More information

Vancomycin Pharmacokinetics. Myrna Y. Munar, Pharm.D., BCPS Associate Professor of Pharmacy

Vancomycin Pharmacokinetics. Myrna Y. Munar, Pharm.D., BCPS Associate Professor of Pharmacy Vancomycin Pharmacokinetics Myrna Y. Munar, Pharm.D., BCPS Associate Professor of Pharmacy Goals Review the PK properties of vancomycin Compare and contrast methods of dosage regimen design for vancomycin

More information

Diane M. Gomes, Pharm.D. Outcomes in Antimicrobial Stewardship Post-Doctoral Pharmacy Fellow Providence Veterans Affairs Medical Center

Diane M. Gomes, Pharm.D. Outcomes in Antimicrobial Stewardship Post-Doctoral Pharmacy Fellow Providence Veterans Affairs Medical Center Diane M. Gomes, Pharm.D. Outcomes in Antimicrobial Stewardship Post-Doctoral Pharmacy Fellow Providence Veterans Affairs Medical Center The information disseminated in this lecture is given in my personal

More information

D DAVID PUBLISHING. Evaluation of the Effectiveness of a Vancomycin Nomogram at Predicting Trough Levels within a Therapeutic Range. 1.

D DAVID PUBLISHING. Evaluation of the Effectiveness of a Vancomycin Nomogram at Predicting Trough Levels within a Therapeutic Range. 1. Journal of Pharmacy and Pharmacology 2 (2014) 713-721 doi: 10.17265/2328-2150/2014.12.004 D DAVID PUBLISHING Evaluation of the Effectiveness of a Vancomycin Nomogram at Predicting Trough Levels within

More information

Is the package insert correct? PK considerations

Is the package insert correct? PK considerations Is the package insert correct? PK considerations Jason A Roberts B Pharm (Hons), PhD, FSHP Professor of Medicine and Pharmacy The University of Queensland, Australia Royal Brisbane and Women s Hospital,

More information

Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review

Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review Journal of Clinical Pharmacy and Therapeutics, 2014, 39, 584 608 doi: 10.1111/jcpt.12200 Review Article Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive

More information

Continuous Infusion of Antibiotics In The ICU: What Is Proven? Professor of Medicine Vice-Chairman, Department of Medicine SUNY at Stony Brook

Continuous Infusion of Antibiotics In The ICU: What Is Proven? Professor of Medicine Vice-Chairman, Department of Medicine SUNY at Stony Brook Continuous Infusion of Antibiotics In The ICU: What Is Proven? Michael S. Niederman, M.D. Chairman, Department of Medicine Winthrop-University Hospital Mineola, NY Professor of Medicine Vice-Chairman,

More information

Stanford Health Care Last Review Date: 8/2016 Pharmacy Department Policies and Procedures

Stanford Health Care Last Review Date: 8/2016 Pharmacy Department Policies and Procedures Medication Administration: Extended-Infusion Piperacillin/Tazobactam (Zosyn ) Protocol Related Documents: Patient Care Manual Guide: Medication Administration IV Infusion Guidelines I. PURPOSE Dose optimization

More information

NHS Grampian Staff Guidance for the Administration of Intravenous Vancomycin in Adults via Intermittent (pulsed) Infusion

NHS Grampian Staff Guidance for the Administration of Intravenous Vancomycin in Adults via Intermittent (pulsed) Infusion Acute Sector NHS Grampian Staff Guidance for the Administration of Intravenous Vancomycin in Adults via Intermittent (pulsed) Infusion Co-ordinators: Gillian Macartney Fiona McDonald Specialist Antibiotic

More information

THE AMINOGLYCOSIDE ANTIBIOTICS

THE AMINOGLYCOSIDE ANTIBIOTICS 4 THE AMINOGLYCOSIDE ANTIBIOTICS INTRODUCTION The aminoglycoside antibiotics are widely used for the treatment of severe gram-negative infections such as pneumonia or bacteremia, often in combination with

More information

MEDICATION MONITORING: Pharmacist-Managed Intravenous (IV) Vancomycin Protocol

MEDICATION MONITORING: Pharmacist-Managed Intravenous (IV) Vancomycin Protocol I. PURPOSE MEDICATION MONITORING: Pharmacist-Managed Intravenous (IV) Vancomycin Protocol To allow standardized pharmacist management of IV vancomycin in the inpatient setting using evidence-based guidelines

More information

December 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide

December 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide Severe Sepsis and Septic Shock Antibiotic Guide Surviving Sepsis: The choice of empirical antimicrobial therapy depends on complex issues related to the patient s history, including drug intolerances,

More information

AMINOGLYCOSIDES TDM D O N E B Y

AMINOGLYCOSIDES TDM D O N E B Y AMINOGLYCOSIDES TDM DONE BY: SARA ALARFAJ 2014 OUTLINE Introduction about Aminoglycosides. Spectrum/uses. TDM Aminoglycosides TDM Pharmacodynamics Pharmacokinetics. Dosing in AG. Sampeling time and Monitoring.

More information

Clinical Study Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations

Clinical Study Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations Interdisciplinary Perspectives on Infectious Diseases Volume 2013, Article ID 839456, 8 pages http://dx.doi.org/10.1155/2013/839456 Clinical Study Prospective Trial of a Novel Nomogram to Achieve Updated

More information

The antibiotic dose and the obese ICU patient

The antibiotic dose and the obese ICU patient The antibiotic dose and the obese ICU patient Philippe Montravers, M.D., Ph.D. Anaesthesia and Surgical ICU CHU Bichat Claude Bernard Assistance Publique-Hôpitaux de Paris INSERM UMR 1152 University Paris

More information

Lessons from recent studies. João Gonçalves Pereira UCIP DALI

Lessons from recent studies. João Gonçalves Pereira UCIP DALI Lessons from recent studies João Gonçalves Pereira UCIP DALI 1 Patterns of Antimicrobial Activity Concentration C max Aminoglycosides Cmax/MIC>10 Metronidazol Area under the concentration curve Azithromycin

More information

A Snapshot of Colistin Use in South-East Europe and Particularly in Greece

A Snapshot of Colistin Use in South-East Europe and Particularly in Greece A Snapshot of Colistin Use in South-East Europe and Particularly in Greece Helen Giamarellou 02.05.2013 When Greek Physicians Prescribe Colistin? It is mainly prescribed in the ICU for VAP, bacteremia

More information

Medication Dosing in CRRT

Medication Dosing in CRRT Medication Dosing in CRRT Linda Awdishu, PharmD, MAS Associate Clinical Professor of Pharmacy and Medicine Learning Objectives 1. List the pharmacokinetic changes associated with AKI. 2. Determine the

More information

Vancomycin: Class: Antibiotic.

Vancomycin: Class: Antibiotic. Vancomycin: Class: Antibiotic. Indications: Treatment of patients with infections caused by staphylococcal species and streptococcal Species. Available dosage form in the hospital: 1G VIAL, 500MG VIAL.

More information

Aminoglycosides John A. Bosso, Pharm.D.

Aminoglycosides John A. Bosso, Pharm.D. AMINOGLYCOSIDES Therapeutics/PHRMP-73 Aminoglycoside Mechanism of Action Aminoglycosides bind to 30s ribosomal subunit resulting in mistranslation of mrna thus disrupting protein synthesis. They are rapidly

More information

Clinical Safety & Effectiveness Cohort # 10

Clinical Safety & Effectiveness Cohort # 10 1 Clinical Safety & Effectiveness Cohort # 10 Improving Weight-Based Vancomycin Dosing and Monitoring DATE Educating for Quality Improvement & Patient Safety 2 Financial Disclosure lizabeth A. Walter,

More information

Challenges in Therapeutic Drug Monitoring:

Challenges in Therapeutic Drug Monitoring: Challenges in Therapeutic Drug Monitoring: Focus on Vancomycin Pharmacodynamics and Pharmacokinetics Katherine Gallaga, PharmD PGY1 Pharmacy Practice Resident CHRISTUS Spohn Health System 1 Pharmacist

More information

Evaluation of Vancomycin Continuous Infusion in Trauma Patients

Evaluation of Vancomycin Continuous Infusion in Trauma Patients OBJECTIVES Evaluation of Vancomycin Continuous Infusion in Trauma Patients Brittany D. Bissell, Pharm.D. PGY-2 Critical Care Pharmacy Resident Jackson Memorial Hospital Miami, Florida Evaluate the potential

More information

PK/PD degli antibiotici utilizzati nella sepsi

PK/PD degli antibiotici utilizzati nella sepsi PK/PD degli antibiotici utilizzati nella sepsi Dario Cattaneo, U.O. Farmacologia Clinica ASST Fatebenefratelli Sacco, Milano Bergamo, città alta Variability of antibiotic concentrations in critically ill

More information

May 11, Ceftriaxone for MSSA. Daptomycin Dosing Weight. Candidiasis Treatment

May 11, Ceftriaxone for MSSA. Daptomycin Dosing Weight. Candidiasis Treatment Diagnostics and Debates: An Update on Rapid Diagnostic Testing and Current Controversies in Infectious Diseases Nicholas Torney, PharmD, BCPS Derek Vander Horst, PharmD Munson Medical Center WMSHP Annual

More information

EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING

EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING EDUCATIONAL COMMENTARY VANCOMYCIN MONITORING Commentary provided by: Julie Hall, MHS, MT (ASCP) Assistant Dean, College of Health Professions Assistant Professor, Medical Laboratory Science Grand Valley

More information

Pneumonia Community-Acquired Healthcare-Associated

Pneumonia Community-Acquired Healthcare-Associated Pneumonia Community-Acquired Healthcare-Associated Edwin Yu Clin Infect Dis 2007;44(S2):27-72 Am J Respir Crit Care Med 2005; 171:388-416 IDSA / ATS Guidelines Microbiology Principles and Practice of Infectious

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A AAP. See American Academy of Pediatrics (AAP) Acyclovir dosing in infants, 185 187 American Academy of Pediatrics (AAP) COFN of, 199 204 Amphotericin

More information

SHC Vancomycin Dosing Guide

SHC Vancomycin Dosing Guide SHC Vancomycin Dosing Guide A: Initial dosing considerations B. Pharmacodynamic Targets: goal AUC and troughs C. Loading dose D: Initial Vancomycin Maintenance Dosing and Serum Concentration Monitoring

More information

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Agenda Discuss 2008 M100- S18

More information

Orchestrated Efforts to Optimize Antibiotic Prescriptions in a Medical Department

Orchestrated Efforts to Optimize Antibiotic Prescriptions in a Medical Department Orchestrated Efforts to Optimize Antibiotic Prescriptions in a Medical Department Dr. Eugene Tso Division of Infectious Diseases Department of Medicine & Geriatrics United Christian Hospital 11 May 2010

More information

PHA Spring First Exam. 8 Aminoglycosides (5 points)

PHA Spring First Exam. 8 Aminoglycosides (5 points) PHA 5128 Spring 2012 First Exam 1 Aminoglycosides (5 points) 2 Aminoglycosides (10 points) 3 Basic Principles (5 points) 4 Basic Principles (5 points) 5 Bioavailability (5 points) 6 Vancomycin (5 points)

More information

Mortality Rate was unsightly!!! 4/24/2013. Sepsis Quality Improvement Project

Mortality Rate was unsightly!!! 4/24/2013. Sepsis Quality Improvement Project Libby, MT Sepsis Quality Improvement Project Barb Dumont RN, Director of Quality and Risk Management Mike Julius RN, ED Manager Cathy Wolfe RN, Chief Nursing Officer. Mortality Rate was unsightly!!! percent

More information

2/6/14. What s Hot in ID Objectives

2/6/14. What s Hot in ID Objectives What s Hot in ID 2014 James S. Lewis II, Pharm.D., FIDSA ID Clinical Pharmacy Coordinator Oregon Health and Science University Portland, OR Objectives Describe highlights of the Interscience Conference

More information

Other β-lactam. A. Carbapenems:

Other β-lactam. A. Carbapenems: A. Carbapenems: Other β-lactam Carbapenems are synthetic β-lactam antibiotics Differ in structure from the penicillins in that the sulfur atom of the thiazolidine ring. Imipenem, meropenem, doripenem,

More information

Counties in the top and bottom two quintiles of both diabetes and obesity, Age-adjusted percentage of adults aged 20 years who are obese, 2007

Counties in the top and bottom two quintiles of both diabetes and obesity, Age-adjusted percentage of adults aged 20 years who are obese, 2007 Impact of Obesity on Medication Dosing John C. Williamson, PharmD, BCPS, AAHIVE Wake Forest University Baptist Medical Center Winston-Salem, NC Objectives Determine what constitutes the various forms of

More information

PPP 1. Continuation, modification, and discontinuation of a medication

PPP 1. Continuation, modification, and discontinuation of a medication PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The

More information

Aminoglycosides. Uses: Treatment of serious gram-negative systemic infections and some grampositive

Aminoglycosides. Uses: Treatment of serious gram-negative systemic infections and some grampositive Aminoglycosides Uses: Treatment of serious gram-negative systemic infections and some grampositive infections such as infective endocarditis. Disadvantage: aminoglycosides are their association with nephrotoxicity

More information

PHARMACOKINETIC & PHARMACODYNAMIC OF ANTIBIOTICS

PHARMACOKINETIC & PHARMACODYNAMIC OF ANTIBIOTICS PHARMACOKINETIC & PHARMACODYNAMIC OF ANTIBIOTICS SITI HIR HURAIZAH MD TAHIR Bpharm (UKM), MSc (Clinical Microbiology) (UoN) CLINICAL PHARMACIST HOSPITAL MELAKA WHY STUDY PHARMACOKINETICS (PK) AND PHARMACODYNAMICS

More information

IV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro

IV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro IV Vancomycin dosing and Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary Medicine Unique

More information

University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology

University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology This material is supported in part by unrestricted educational

More information

Cystic Fibrosis: Pulmonary Exacerbations Management Guidelines

Cystic Fibrosis: Pulmonary Exacerbations Management Guidelines Cystic Fibrosis: Pulmonary Exacerbations Management Guidelines Inclusion Criteria: Age 1 year with cystic fibrosis admitted for a pulmonary exacerbation. Exclusion Criteria: ICU Admission Newborn with

More information

CLINICAL USE OF GLYCOPEPTIDES. Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel

CLINICAL USE OF GLYCOPEPTIDES. Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel CLINICAL USE OF GLYCOPEPTIDES Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel Glycopeptides Natural Vancomycin introduced in 1958 Teicoplanin introduced in Europe

More information

Sep Oct Nov Dec Total

Sep Oct Nov Dec Total LB PAGE 2 LB PAGE 3 Sep Oct Nov Dec 2007 2007 2007 2007 Total Repeat Information Total Repeats 35 15 17 9 76 Repeat Rate 6.01% 0.17% 1.12% 0.39% 2.07% Repeat Chemistry 25 0 2 0 27 Repeat Extraction 1 0

More information

Experience with a Once-Daily Aminoglycoside Program Administered to 2,184 Adult Patients

Experience with a Once-Daily Aminoglycoside Program Administered to 2,184 Adult Patients ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Mar. 1995, p. 650 655 Vol. 39, No. 3 0066-4804/95/$04.00 0 Copyright 1995, American Society for Microbiology Experience with a Once-Daily Aminoglycoside Program Administered

More information

The Challenge of Managing Staphylococcus aureus Bacteremia

The Challenge of Managing Staphylococcus aureus Bacteremia The Challenge of Managing Staphylococcus aureus Bacteremia M A R G A R E T G R A Y B S P F C S H P C L I N I C A L P R A C T I C E M A N A G E R N O R T H / I D P H A R M A C I S T A L B E R T A H E A

More information

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and 5 Infections To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and Southend University Hospital, Antibiotic Guidelines Index 5.1 Antibacterial drugs

More information

Optimizing antifungal dosing regimens. Joseph Meletiadis, PhD, FECMM Assistant Professor of Microbiology

Optimizing antifungal dosing regimens. Joseph Meletiadis, PhD, FECMM Assistant Professor of Microbiology ATHENA 2017 International Conference November 28 30, 2017 Optimizing antifungal dosing regimens Joseph Meletiadis, PhD, FECMM Assistant Professor of Microbiology Clinical Microbiology Laboratory, «Attikon»

More information

Should we be performing TDM in seriously ill patients with Gram negative infections?

Should we be performing TDM in seriously ill patients with Gram negative infections? Should we be performing TDM in seriously ill patients with Gram negative infections? Jason A Roberts B Pharm (Hons), PhD, FSHP Royal Brisbane and Women s Hospital, Australia. The University of Queensland,

More information

MICHIGAN MEDICINE GUIDELINES FOR TREATMENT OF URINARY TRACT INFECTIONS IN ADULTS

MICHIGAN MEDICINE GUIDELINES FOR TREATMENT OF URINARY TRACT INFECTIONS IN ADULTS When to Order a Urine Culture: Asymptomatic bacteriuria is often treated unnecessarily, and accounts for a substantial burden of unnecessary antimicrobial use. National guidelines recommend against testing

More information

Infections Amenable to OPAT. (Nabin Shrestha + Ajay Mathur)

Infections Amenable to OPAT. (Nabin Shrestha + Ajay Mathur) 3 Infections Amenable to OPAT (Nabin Shrestha + Ajay Mathur) Decisions regarding outpatient treatment of infections vary with the institution, the prescribing physician, the individual patient s condition

More information

Alternative Dosing for IV Antibiotics

Alternative Dosing for IV Antibiotics This Clinical Resource gives subscribers additional insight related to the Recommendations published in January 2018 ~ Resource #340121 Alternative Dosing for IV Antibiotics Intravenous medications are

More information

Evaluation of Vancomycin Dosing and Corresponding Drug Concentrations in Pediatric Patients

Evaluation of Vancomycin Dosing and Corresponding Drug Concentrations in Pediatric Patients RESEARCH ARTICLE Evaluation of Vancomycin Dosing and Corresponding Drug Concentrations in Pediatric Patients abstract OBJECTIVE: To describe the relationships between dosing strategy, age, and vancomycin

More information

PALO VERDE HEALTH CARE DISTRICT REGULAR BOARD OF DIRECTORS MEETING MINUTES July 27, 2016 City Council Chambers

PALO VERDE HEALTH CARE DISTRICT REGULAR BOARD OF DIRECTORS MEETING MINUTES July 27, 2016 City Council Chambers PVHD BOD Meeting Minutes July 27, 2016 Page 1 of 6 PALO VERDE HEALTH CARE DISTRICT REGULAR BOARD OF DIRECTORS MEETING MINUTES July 27, 2016 City Council Chambers Directors Present Administrative Staff

More information

Joint Trust Guideline for the Use of Intravenous Vancomycin in Paediatrics

Joint Trust Guideline for the Use of Intravenous Vancomycin in Paediatrics A clinical guideline recommended For use in: All clinical areas where vancomycin is prescribed for Children aged 1 month to 16 years By: All medical, nursing, pharmacy, microbiology and phlebotomy paediatric

More information

Effect of piperacillin/tazobactam restriction on usage and rates of acute renal failure

Effect of piperacillin/tazobactam restriction on usage and rates of acute renal failure Journal of Medical Microbiology (2016), 65, 195 199 DOI 10.1099/jmm.0.000211 Effect of piperacillin/tazobactam restriction on usage and rates of acute renal failure Michael A. Lorenz, 1,2 Ryan P. Moenster

More information

Giving the Proper Dose: How Can The Clinical and Laboratory Standards Institute(CLSI)Help?

Giving the Proper Dose: How Can The Clinical and Laboratory Standards Institute(CLSI)Help? Giving the Proper Dose: How Can The Clinical and Laboratory Standards Institute(CLSI)Help? Pranita D. Tamma, M.D., M.H.S. Director, Pediatric Antimicrobial Stewardship Johns Hopkins University School of

More information

Annual Surveillance Summary: Pseudomonas aeruginosa Infections in the Military Health System (MHS), 2016

Annual Surveillance Summary: Pseudomonas aeruginosa Infections in the Military Health System (MHS), 2016 Annual Surveillance Summary: Pseudomonas aeruginosa Infections in the Military Health System (MHS), 2016 Sarah Gierhart and Uzo Chukwuma Approved for public release. Distribution is unlimited. The views

More information

GUIDELINES FOR USERS ANTIMICROBIAL REFERENCE LABORATORY ASSAY SERVICE. 17th Edition

GUIDELINES FOR USERS ANTIMICROBIAL REFERENCE LABORATORY ASSAY SERVICE. 17th Edition ANTIMICROBIAL REFERENCE LABORATORY ASSAY SERVICE GUIDELINES FOR USERS 17th Edition 2011 Earlier editions should be destroyed Antimicrobial Reference Laboratory Department of Medical Microbiology North

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy

Severe β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.

More information

Antibiotic Dosing in the Elderly

Antibiotic Dosing in the Elderly Antibiotic Dosing in the Elderly Philip Chung, PharmD, MS, BCPS Nebraska ASAP Community Network Pharmacy Coordinator Nebraska Medicine Disclosure I have no relevant disclosure The presentation includes

More information

Chapter 5 ~ Infections

Chapter 5 ~ Infections Chapter 5 ~ Infections: Special Section 1 of 6 Chapter 5 ~ Infections Please refer to The Hillingdon Hospitals NHS Trust Antibiotic Guidelines, Policy number 233, and Surgical Prophylaxis Policy, Policy

More information

Cubicin A Guide to Dosing

Cubicin A Guide to Dosing Cubicin A Guide to Dosing Cubicin (Daptomycin) powder for solution for injection or infusion Indications (see SmPC) 1 : Cubicin is indicated for the treatment of the following infections (see sections

More information

PHA5128 Dose Optimization II Case Study 3 Spring 2013

PHA5128 Dose Optimization II Case Study 3 Spring 2013 Use the vancomycin dosing nomogram table below: A female patient, 57 years of age, 5 6 in height and 100 in weight had an infection requiring vancomycin treatment. Her serum creatinine was 0.8 mg/d. What

More information

Shaukat Khanum Memorial Cancer Hospital and Research Center. Volume V, Issue # 1, 2015

Shaukat Khanum Memorial Cancer Hospital and Research Center. Volume V, Issue # 1, 2015 Shaukat Khanum Memorial Cancer Hospital and Research Center Volume V, Issue # 1, 2015 The Team Muhammad Tahir Aziz Associate Director Pharmaceutical & Ambulatory Services Sidrah Andleeb Senior Clinical

More information

Healthy Adult cuti Patient. Cmax (mcg/ml)(mean ± SD) 73.7 ± ± 113. Vd (L)(mean ± SD) 17.9 ± ± 12.1

Healthy Adult cuti Patient. Cmax (mcg/ml)(mean ± SD) 73.7 ± ± 113. Vd (L)(mean ± SD) 17.9 ± ± 12.1 Brand Name: Zemdri Generic Name: plazomicin Manufacturer: Achaogen, Inc Drug Class: aminoglycoside antibacterial Uses: 1-5 Labeled: treatment of complicated urinary tract infections (cuti), including pyelonephritis,

More information

UPDATE ON FEBRILE NEUTROPENIA

UPDATE ON FEBRILE NEUTROPENIA UPDATE ON FEBRILE NEUTROPENIA Clinical approach and management Dr.Shafiq A. Alimad Head of medical department at university of science and technology hospital YICID 15-December-2014 INTRODUCTION Cancer

More information

Outline of presentation. Pinyo Rattanaumpawan; Sajja Supornpun; Basic Concepts of ASP Research to Practice in ASP ASP Siriraj

Outline of presentation. Pinyo Rattanaumpawan; Sajja Supornpun; Basic Concepts of ASP Research to Practice in ASP ASP Siriraj 1 Pinyo Rattanaumpawan; MD, MSCE, PhD Division of Infectious Diseases and Tropical Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University Sajja Supornpun; BPharm, MS Department of Pharmacy,

More information

Abstract. Background. Editor: M. Grobusch

Abstract. Background. Editor: M. Grobusch ORIGINAL ARTICLE INFECTIOUS DISEASES Acute renal failure associated with vancomycin and b-lactams for the treatment of osteomyelitis in diabetics: piperacillin tazobactam as compared with cefepime R. P.

More information

Optimizing Antibiotic Therapy in the ICU For Pneumonia Current and Future Approaches

Optimizing Antibiotic Therapy in the ICU For Pneumonia Current and Future Approaches Optimizing Antibiotic Therapy in the ICU For Pneumonia Current and Future Approaches Andrew F. Shorr, MD, MPH Washington Hospital Center Georgetown Univ. Disclosures I have served as a consultant to, researcher/investigator

More information

Neutropenic Sepsis Guideline

Neutropenic Sepsis Guideline Neutropenic Sepsis Guideline Neutropenic Sepsis Guideline - definitions Suspected or proven infection in a neutropenic patient is a MEDICAL EMERGENCY and is an indication for immediate assessment and prompt

More information

Cystatin C: A New Approach to Improve Medication Dosing

Cystatin C: A New Approach to Improve Medication Dosing Cystatin C: A New Approach to Improve Medication Dosing Erin Frazee Barreto, PharmD, MSc, FCCM Assistant Professor of Pharmacy and Medicine Kern Scholar, Center for the Science of Health Care Delivery

More information

Use of Antibacterial Agents in Renal Failure

Use of Antibacterial Agents in Renal Failure Use of Antibacterial Agents in Renal Failure Brett Gilbert, DO a, *, Paul Robbins, DO b, Lawrence L. Livornese Jr, MD, FIDSA c KEYWORDS Antibiotics Renal failure Volume of distribution MDRD Dosing antibiotics

More information

Intravenous Vancomycin Use Adult Inpatient/Ambulatory Clinical Practice Guideline

Intravenous Vancomycin Use Adult Inpatient/Ambulatory Clinical Practice Guideline Intravenous Vancomycin Use Adult Inpatient/Ambulatory Clinical Practice Guideline Table of Contents INTRODUCTION... 3 SCOPE... 3 RECOMMENDATIONS... 5 TABLE 1. EMPIRIC INTERMITTENT VANCOMYCIN DOSING NOMOGRAM...

More information